Patent · US Active

Pyrimidine derivatives for the treatment of viral infections

US9422250B2 · kind B2 · utility

29Cited by

2References

15Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

David Craig MC GOWAN · Brussels, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Werner Constant Johan Embrechts · Beerse, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Stefaan Julien Last · Lint, BE
Serge Maria Aloysius Pieters · Wichelen, BE
Jaromir Vlach · Bonneville, FR

Key dates

Filing date	Apr 10, 2012
Grant date	Aug 23, 2016
Priority date	—
Expiry date	May 6, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.